Bosh sahifaONC • TSE
add
Oncolytics Biotech Inc
Yopilish kursi
0,82 $
Kunlik diapazon
0,78 $ - 0,82 $
Yillik diapazon
0,67 $ - 2,08 $
Bozor kapitalizatsiyasi
62,42 mln CAD
Oʻrtacha hajm
57,69 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 8,44 mln | -4,66% |
Sof foyda | -8,02 mln | -103,01% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,10 | 9,91% |
EBITDA | -8,43 mln | 4,56% |
Amaldagi soliq stavkasi | -0,29% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 15,94 mln | -54,34% |
Jami aktivlari | 20,19 mln | -48,00% |
Jami passivlari | 14,20 mln | 26,18% |
Umumiy kapital | 5,98 mln | — |
Tarqatilgan aksiyalar | 86,42 mln | — |
Narxi/balansdagi bahosi | 11,71 | — |
Aktivlardan daromad | -94,91% | — |
Kapitaldan daromad | -245,72% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -8,02 mln | -103,01% |
Operatsiyalardan naqd pul | -7,85 mln | -28,12% |
Sarmoyadan naqd pul | -6,00 ming | -100,00% |
Moliyadan naqd pul | 3,34 mln | 91,68% |
Naqd pulning sof oʻzgarishi | -3,66 mln | 27,88% |
Boʻsh pul | -4,62 mln | 44,28% |
Haqida
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Tashkil etilgan
1998
Bosh ofis
Xodimlar soni
28
